Patent · US Expired

Certain aryl substituted pyrrolopyrazines; a new class of gaba brain receptor ligands

US5606059A · kind A · utility

4Cited by
6References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 12, 1995
Grant dateFeb 25, 1997
Priority date
Expiry dateMay 12, 2015

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention encompasses compounds of formula (I) and pharmaceutically acceptable non-toxic salts thereof wherein (Ia) represents (i) or (ii) where n is 0, 1, or 2: R.sub.1 and R.sub.2 are hydrogen or straight or branched chain alkyl groups; Y various organic and inorganic substituents; W represents an aromatic group substituted with various organic and inorganic substituents; A is CH or N; B is a substituted or unsubstituted carbon or N; and E is hydrogen or straight or branched alkyl groups. These compounds are highly selective agonists, antagonists or inverse agonists for GABAa brain receptors or prodrugs thereof and are useful in the diagnosis and treatment of anxiety, sleep, and seizure disorders, overdose with benzodiazepine type drugs, and enhancement of alertness.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.